FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine, specifically to ophthalmology, and is intended for the treatment of dry eyes. Ophthalmic composition for treating dry eyes contains 0.1 to 0.2 w/v% galactomannan, 0.05 to 0.5 w/v% hyaluronic acid, and 1.0 to 2.0 w/v% sorbitol. In order to treat dry eyes, the composition is administered to the eyes of a patient in need of such treatment.
EFFECT: use of the group of inventions makes improves the efficiency of treating dry eyes by improving the protection of the cornea from dehydration, and also improves protection due to retention of the composition on the surface of the eye.
8 cl, 7 tbl, 4 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLUBLE POLYMER EYE INSERTS AND THEIR APPLICATION METHOD | 2020 |
|
RU2791026C1 |
| SOLUBLE POLYMERIC OPHTHALMIC INLAYS WITH BIODEGRADABLE POLYMER | 2020 |
|
RU2802441C1 |
| LIPID-BASED OPHTHALMIC EMULSION | 2019 |
|
RU2793333C2 |
| OPHTHALMIC COMPOSITIONS WITH POLY(ETHYLENE OXIDE)-POLY(BUTYLENE OXIDE) BLOCK COPOLYMERS | 2010 |
|
RU2548789C2 |
| OPHTHALMIC COMPOSITIONS | 2020 |
|
RU2798842C1 |
| ARTIFICIAL TEARS COMPRISING SODIUM HYALURONATE AND CARBOXYMETHYLCELLULOSE | 2014 |
|
RU2687275C2 |
| SUSPENSIONS OF NANOPARTICLES, CONTAINING CARBOXYVINYL POLYMER | 2010 |
|
RU2571078C2 |
| METHODS AND COMPOSITIONS FOR TREATING DRY EYE | 2008 |
|
RU2470662C2 |
| COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS | 2020 |
|
RU2795913C2 |
| COMPOSITIONS AND METHODS OF TREATING EYE DISORDERS | 2020 |
|
RU2802625C2 |
